SPTX

Seaport Therapeutics, Inc. - Common Stock (SPTX)

About Seaport Therapeutics, Inc. - Common Stock (SPTX)

Seaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company was founded on April 1, 2024 and is headquartered in Boston, MA.

Details

Daily high

$22.68

Daily low

$21.28

Price at open

$21.89

52 Week High

$28.38

52 Week Low

$14.85

Market cap

1.2B

Dividend yield

Volume

306,863

Avg. volume

242,967

P/E ratio

-8.31

Seaport Therapeutics, Inc. - Common Stock News